These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9617206)

  • 1. [Transgenic mice in basic research].
    Gassmann M; Hennet T; Bauer C
    Schweiz Arch Tierheilkd; 1998; 140(5):198-204. PubMed ID: 9617206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified mouse models in studies on cutaneous wound healing.
    Scheid A; Meuli M; Gassmann M; Wenger RH
    Exp Physiol; 2000 Nov; 85(6):687-704. PubMed ID: 11187964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of phenotype in genetically engineered mice.
    Doetschman T
    Lab Anim Sci; 1999 Apr; 49(2):137-43. PubMed ID: 10331542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic and gene knock-out techniques and burn research.
    Wolf SE; Woodside KJ
    J Surg Res; 2005 Feb; 123(2):328-39. PubMed ID: 15680397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor IX: Insights from knock-out and genetically engineered mice.
    Monahan PE
    Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis.
    Douni E; Akassoglou K; Alexopoulou L; Georgopoulos S; Haralambous S; Hill S; Kassiotis G; Kontoyiannis D; Pasparakis M; Plows D; Probert L; Kollias G
    J Inflamm; 1995-1996; 47(1-2):27-38. PubMed ID: 8913927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of wound healing: utility in transgenic mice.
    Fang RC; Mustoe TA
    J Biomater Sci Polym Ed; 2008; 19(8):989-1005. PubMed ID: 18644226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered mouse models in drug discovery research.
    Sacca R; Engle SJ; Qin W; Stock JL; McNeish JD
    Methods Mol Biol; 2010; 602():37-54. PubMed ID: 20012391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific transgenic and knockout mice.
    Porret A; Mérillat AM; Guichard S; Beermann F; Hummler E
    Methods Mol Biol; 2006; 337():185-205. PubMed ID: 16929948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research.
    Bolon B
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):154-61. PubMed ID: 15504150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of wound healing: pursuing surgical models in transgenic and knockout mice.
    Reid RR; Said HK; Mogford JE; Mustoe TA
    J Am Coll Surg; 2004 Oct; 199(4):578-85. PubMed ID: 15454143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models.
    Kruglov AA; Kuchmiy A; Grivennikov SI; Tumanov AV; Kuprash DV; Nedospasov SA
    Cytokine Growth Factor Rev; 2008; 19(3-4):231-44. PubMed ID: 18502680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.
    Edwards CK; Bendele AM; Reznikov LI; Fantuzzi G; Chlipala ES; Li L; Moldawer LL; Mountz JD; Li YY; Dinarello CA
    Arthritis Rheum; 2006 Sep; 54(9):2872-85. PubMed ID: 16947419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future approaches using genetically modified mice in endocrine research.
    Davey RA; MacLean HE
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E429-38. PubMed ID: 16684850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic engineering in the mouse: tuning TNF/TNFR expression.
    Douni E; Alexiou M; Kollias G
    Methods Mol Med; 2004; 98():137-70. PubMed ID: 15064438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The program for phenotyping of genetically modified animals at AstraZeneca.
    Berg AL; Bohlooly-Y M
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):383-4. PubMed ID: 16709449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: Strategies for developing genetically modified mice.
    Hofker MH
    Methods Mol Biol; 2011; 693():1-10. PubMed ID: 21080271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetically engineered mice and its application to bioindustry].
    Koda T; Togashi Y; Nishimura T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
    Kinbara T; Shirasaki F; Kawara S; Inagaki Y; de Crombrugghe B; Takehara K
    J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using knockout mice to study experimental meningitis.
    Paul R; Koedel U; Pfister HW
    Arch Immunol Ther Exp (Warsz); 2003; 51(5):315-26. PubMed ID: 14626431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.